Core Laboratories (NYSE:CLB) Reaches New 12-Month Low - Time to Sell?

Core Laboratories Inc. (NYSE:CLB - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $12.95 and last traded at $13.71, with a volume of 729774 shares. The stock had previously closed at $13.81.

Analyst Ratings Changes

Separately, Citigroup increased their target price on shares of Core Laboratories from $14.00 to $15.00 and gave the stock a "sell" rating in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to MarketBeat.com, Core Laboratories presently has an average rating of "Hold" and an average target price of $17.25.

Core Laboratories Stock Performance

The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. The business's fifty day simple moving average is $17.38 and its 200-day simple moving average is $18.44. The firm has a market capitalization of $697.68 million, a PE ratio of 22.57, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. As a group, equities research analysts expect that Core Laboratories Inc. will post 0.96 EPS for the current year.

Remove Ads

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories's dividend payout ratio (DPR) is currently 6.06%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Assetmark Inc. bought a new position in shares of Core Laboratories during the 4th quarter valued at approximately $26,000. Smartleaf Asset Management LLC boosted its position in shares of Core Laboratories by 173.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock valued at $35,000 after acquiring an additional 1,293 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of Core Laboratories by 2,688.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company's stock valued at $42,000 after acquiring an additional 2,339 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in shares of Core Laboratories by 843.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company's stock valued at $57,000 after acquiring an additional 2,936 shares during the last quarter. Finally, BNP Paribas Financial Markets bought a new position in shares of Core Laboratories during the 4th quarter valued at approximately $123,000. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.